Find a specific notice:
Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Publication Date
1 Nov 2018

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2018-go5454
Title
View PDF
File Type and Size
PDF (29 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredients:

Dosage Form:
New Zealand Sponsor:
Manufacturers:

Moxifloxacin Kabi
Moxifloxacin hydrochloride 1.75mg/mL
equivalent to moxifloxacin 1.6mg/mL
Solution for infusion
Fresenius Kabi New Zealand Limited
Fresenius Kabi Norge AS, Halden, Norway
Fresenius Kabi Polska Sp. z o.o., Kutno, Poland

Product:
Active Ingredients:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Naloxone Multichem
Naloxone hydrochloride dihydrate 0.44mg/mL
equivalent to naloxone hydrochloride 0.4mg/mL
Solution for injection
Multichem NZ Limited
Medochemie Limited, Limassol, Cyprus

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Riximyo
Rituximab 10mg/mL
Concentrate for infusion
Novartis New Zealand Limited
Lek Pharmaceuticals d.d., Ljubljana, Slovenia

Dated this 29th day of October 2018.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).